|
Delayed
Börse Stuttgart
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-26.55% | -38.10% |
| 10-05 | Oppenheimer Initiates Coverage on CAMP4 Therapeutics With Outperform Rating, $15 Price Target | MT |
| 09-29 | Chardan Trims Price Target on CAMP4 Therapeutics to $6 From $6.50, Keeps Buy Rating | MT |
Stock exchange
Börse Stuttgart
CF30 - €
-.--%
0
€
| Markets | Price | Change | Volumes |
|---|
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
120,572
Market Cap (USD)
120,572
Free-Float
100%
Free-Float capitalization (EUR)
115,559
Free-Float capitalization (USD)
115,559
Indicators
Moving average 5 days
3.349
Moving average 100 days
6.229
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -26.55% | - | - | 121K | |
| +5.81% | +4.18% | - | - | 1,929B | |
| +4.14% | +5.34% | -18.50% | +14.85% | 179B | |
| +0.79% | +1.68% | -12.20% | +39.48% | 147B | |
| -1.49% | +3.96% | +3.19% | +121.50% | 137B | |
| +14.85% | -8.22% | -29.58% | +170.67% | 123B | |
| +0.49% | +2.68% | -10.38% | -40.04% | 87.04B | |
| -1.72% | +0.43% | +5.59% | +32.75% | 72.35B | |
| +1.12% | +1.19% | +8.26% | +23.39% | 65.91B | |
| +0.39% | +0.09% | +32.36% | +50.75% | 36.12B | |
| Average | +1.79% | -0.47% | -2.66% | +51.67% | 278B | |
| Weighted average by Cap. | +0.85% | +2.63% | -8.35% | +57.06% |
Historical Quotes: CalAmp Corp.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- CAMP Stock
- CF30 Stock
- Quotes CalAmp Corp.
Select your edition
All financial news and data tailored to specific country editions
